ErVaccine closes a €4.5 million financing round and prepares to start clinical trial with its first therapeutic cancer vaccine in 2023

ErVaccine is developing a therapeutic vaccine and cell therapy technology [...]

ErVaccine closes a €4.5 million financing round and prepares to start clinical trial with its first therapeutic cancer vaccine in 20232023-01-06T13:46:28+00:00

ErVaccine Technologies announces the publication of a new paper in American Journal of Hematology

ErVaccine Technologies, a preclinical-stage biotechnology company, announces the publication of [...]

ErVaccine Technologies announces the publication of a new paper in American Journal of Hematology2022-06-29T08:59:43+00:00

ErVaccine Technologies announces the publication of a new paper in European Journal of Cancer journal

ErVaccine Technologies, a preclinical-stage biotechnology company, today announces the publication [...]

ErVaccine Technologies announces the publication of a new paper in European Journal of Cancer journal2022-06-16T07:46:46+00:00
Go to Top